Stay updated on CC-97540 in Severe SLE Clinical Trial
Sign up to get notified when there's something new on the CC-97540 in Severe SLE Clinical Trial page.
Latest updates to the CC-97540 in Severe SLE Clinical Trial page
- Check2 days agoChange DetectedSite 0053 entry updated to Charité - Universitaetsmedizin Berlin, Campus Bejnamin Franklin (Berlin) with Active, not recruiting status, replacing the previous University of Illinois at Chicago entry and Charité Mitte contact. The former Damiano Rondelli, Site 0053, and Charité Mitte contact have been removed.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedMinor visual/layout adjustments detected on the Study Details page, with no updates to core content such as the study title, status, locations, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check23 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT05869955; core information such as the study title, conditions, interventions, and locations remains unchanged.SummaryDifference0.1%
- Check30 days agoChange DetectedThe update adds an expanded list of study locations across US and international sites and updates eligibility criteria language for SLE, IIM, SSc, and RA cohorts, while removing several previous location blocks.SummaryDifference2%
- Check44 days agoChange DetectedNo significant changes detected between the old and new screenshots; observed differences are minor UI/layout updates and non-substantive wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check51 days agoChange DetectedAdded an estimated Last Update Posted timestamp and a new Revision label (v3.3.2) to the study page. The previous Last Update Posted entry and the older revision label (v3.2.0) were removed.SummaryDifference0.1%
Stay in the know with updates to CC-97540 in Severe SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-97540 in Severe SLE Clinical Trial page.